Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis
Authors:
- 15 August 2013
- journal article
- research article
- Published by Springer Nature in International Journal of Hematology
- Vol. 98 (3) , 366-374
Abstract
Angioimmunoblastic T-cell lymphoma (AITL) is a rare subtype of non-Hodgkin lymphoma characterized by aggressive symptoms and various abnormal laboratory test results. One of the rare immunologic abnormalities in AITL is exuberant polyclonal plasmacytosis, but its clinical significance has not been evaluated. This report concerns three AITL cases with exuberant polyclonal plasmacytosis and investigates its clinical impact by comparison with 12 patients without plasmacytosis. Our study found that the performance status (PS) of the former was significantly worse and their serum immunoglobulin levels were significantly higher. All other parameters, including B symptoms, various prognostic scores, blood cell counts other than plasmacyte, and serum levels of lactate dehydrogenase, C-reactive protein and soluble interleukin-2 receptor, showed no significant differences. More importantly, although the diagnosis of AITL with plasmacytosis was not straightforward in our series, outcomes of treatment with conventional chemotherapy or immunosuppressive therapy with cyclosporine A were favorable. To conclude, AITL should be considered a candidate underlying disease of exuberant polyclonal plasmacytosis. Provided a correct diagnosis is made early and is followed by adequate treatment, the prognosis for AITL with plasmacytosis may not be worse than that for those without plasmacytosis despite the severe exhaustion at first presentation.Keywords
This publication has 29 references indexed in Scilit:
- Analysis of 142 Northern Chinese Patients With Peripheral T/NK-Cell LymphomasAmerican Journal of Clinical Pathology, 2012
- Atypical angioimmunoblastic T-cell lymphomas masquerading as systemic polyclonal B-immunoblastic proliferationVirchows Archiv, 2012
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaBlood, 2010
- Angioimmunoblastic T-cell lymphomaCritical Reviews in Oncology/Hematology, 2008
- Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trialsBlood, 2008
- Spectrum of bone marrow findings in patients with angioimmunoblastic T‐cell lymphomaBritish Journal of Haematology, 2007
- Distinguishing angioimmunoblastic T‐cell lymphoma from peripheral T‐cell lymphoma, unspecified, using morphology, immunophenotype and molecular geneticsHistopathology, 2007
- Angioimmunoblastic T cell lymphoma: Treatment experience with cyclosporineLeukemia & Lymphoma, 2007
- Angioimmunoblastic T-Cell Lymphoma with Polyclonal Proliferation of Plasma Cells in Peripheral Blood and MarrowActa Haematologica, 2006
- Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical studyBlood, 2004